ArticleVascular specialist international2026
Complex Management of an Infectious Aortic Pseudoaneurysm Secondary to Disseminated Tuberculosis in a Patient with Systemic Lupus Erythematosus and End-Stage Renal Disease: A Case Report.
Article in Vascular specialist international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious aortic pseudoaneurysm secondary to disseminated tuberculosis is rare and potentially fatal, particularly in immunocompromised patients. We report a 37-year-old female patient with systemic lupus erythematosus and end-stage renal disease on immunosuppressive therapy and hemodialysis who presented with post-dialysis fever. Computed tomography angiography (CTA) revealed a descending thoracic aortic pseudoaneurysm. During hospitalization, she developed persistent fever, abdominal pain, and lower-extremity purpura. Urgent thoracic endovascular aortic repair (TEVAR) was performed using a 24×100 mm single thoracic stent-graft. Post-TEVAR CTA demonstrated a persistent endoleak, raising concern for a distal type Ib versus type III endoleak; therefore, left thoracotomy was performed, and a type III endoleak was confirmed intraoperatively. Tuberculous aortitis was confirmed by GeneXpert (Cepheid) analysis of the aortic tissue. Renal-adjusted antitubercular therapy was administered with favorable clinical and imaging outcomes. This case highlights the importance of early recognition and multidisciplinary management of tuberculous aortitis in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.